Merck Hepatitis C exit could lift the space’s two remaining drugmakers By: MarketWatch September 29, 2017 at 13:23 PM EDT “This, in a nutshell, changes everything,” one Wall Street analyst said. Read More >> Related Stocks: AbbVie Gilead Sciences Johnson & Johnson Merck & Co